Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The burden of liver disease in Europe: a review of available epidemiological data.

Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F.

J Hepatol. 2013 Mar;58(3):593-608. doi: 10.1016/j.jhep.2012.12.005. Review.

2.

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.

Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U.

BMC Public Health. 2009 Jan 22;9:34. doi: 10.1186/1471-2458-9-34. Review.

3.

Liver disease in Europe.

Burroughs A, McNamara D.

Aliment Pharmacol Ther. 2003 Nov;18 Suppl 3:54-9. Review. No abstract available.

4.

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.

Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, Colombo M, Delarocque-Astagneau E, Dusheiko G, Esmat G, Esteban R, Goldberg D, Gore C, Lok AS, Manns M, Marcellin P, Papatheodoridis G, Peterle A, Prati D, Piorkowsky N, Rizzetto M, Roudot-Thoraval F, Soriano V, Thomas HC, Thursz M, Valla D, van Damme P, Veldhuijzen IK, Wedemeyer H, Wiessing L, Zanetti AR, Janssen HL.

J Viral Hepat. 2011 Sep;18 Suppl 1:1-16. doi: 10.1111/j.1365-2893.2011.01499.x.

5.

Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.

Bird SM, Goldberg DJ, Hutchinson SJ.

J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.

PMID:
11437088
6.

The burden of viral hepatitis in Africa.

Bojuwoye BJ.

West Afr J Med. 1997 Oct-Dec;16(4):198-203.

PMID:
9473953
7.

[Estimation on disease burden related to hepatitis B virus infection in Shandong province of China].

Qi WT, Sun JD, Xu AQ, Zhang L, Li RP, Ma JX, Guo XL, Fan QY, Yang H.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Jul;30(7):679-83. Chinese.

PMID:
19957589
8.

The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.

Giannousis IP, Papatheodoridis GV, Deutsch MJ, Manolakopoulos SG, Manesis EK, Koskinas JS, Archimandritis AJ.

Eur J Gastroenterol Hepatol. 2010 Feb;22(2):172-9. doi: 10.1097/MEG.0b013e328331115b.

PMID:
19738477
9.

Type and cause of liver disease in Korea: single-center experience, 2005-2010.

Lee SS, Byoun YS, Jeong SH, Kim YM, Gil H, Min BY, Seong MH, Jang ES, Kim JW.

Clin Mol Hepatol. 2012 Sep;18(3):309-15. doi: 10.3350/cmh.2012.18.3.309. Epub 2012 Sep 25.

10.

[Prevalence of chronic hepatic disease in Portugal. Apropos of a review carried out in a hepatology unit].

Valente AI, Almeida A, Gouveia A, Serejo F, Ramalho F, Baptista A, Saragoça A, Moura MC.

Acta Med Port. 1996 Jul-Sep;9(7-9):197-202. Portuguese.

11.

Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.

Jazag A, Puntsagdulam N, Chinburen J.

Korean J Intern Med. 2012 Jun;27(2):121-7. doi: 10.3904/kjim.2012.27.2.121. Epub 2012 May 31. Review.

12.

The global impact of hepatic fibrosis and end-stage liver disease.

Lim YS, Kim WR.

Clin Liver Dis. 2008 Nov;12(4):733-46, vii. doi: 10.1016/j.cld.2008.07.007. Review.

PMID:
18984463
13.

[Epidemiology of liver diseases in the GDR, 1979-1989].

Truckenbrodt J, Schmidt H, Bohndorf HJ.

Gastroenterol J. 1991;51(3-4):129-31. German.

PMID:
1811656
14.

Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.

Trombetta M, Spiazzi G, Zoppini G, Muggeo M.

Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:24-7. Review.

15.

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study.

Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G.

Hepatology. 1994 Dec;20(6):1442-9.

PMID:
7982643
16.

Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.

Lu J, Xu A, Wang J, Zhang L, Song L, Li R, Zhang S, Zhuang G, Lu M.

BMC Health Serv Res. 2013 Jan 31;13:37. doi: 10.1186/1472-6963-13-37.

17.

Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states.

Méndez-Sánchez N, García-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, Kobashi-Margáin RA, Gutiérrez-Grobe Y, Chávez-Tapia N, Ponciano-Rodríguez G, Uribe M.

Ann Hepatol. 2010 Oct-Dec;9(4):428-38.

PMID:
21057162
18.

Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem.

García-Fulgueiras A, García-Pina R, Morant C, de Larrea-Baz NF, Alvarez E.

J Viral Hepat. 2011 Oct;18(10):e453-60. doi: 10.1111/j.1365-2893.2011.01467.x. Epub 2011 Jun 1.

PMID:
21914063
19.

The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C.

Zani C, Pasquale L, Bressanelli M, Puoti M, Paris B, Coccaglio R, Lascioli I, Pieriacci G, Donato F.

Dig Liver Dis. 2011 Aug;43(8):653-8. doi: 10.1016/j.dld.2011.03.007. Epub 2011 Apr 29.

PMID:
21530428
20.

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk